Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system

Molecular and Cellular Endocrinology

Volumn 333, Issue 1, 2011, Pages 78-84

  Araujo, A S R ^a   Diniz, G P ^b   Seibel, F E R ^a   Branchini, G ^a   Ribeiro, M F M ^a   Brum, I S ^a   Khaper, N ^c   Barreto Chaves, M L M ^b   Bello Klein A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cardiac hypertrophy; Nitric oxide; Renin angiotensin system; Superoxide anion; Thyroid hormones

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DENATURATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; THYROID HORMONE BLOOD LEVEL; TISSUE HOMOGENATE; UPREGULATION;

ANGIOTENSINOGEN; ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; CELLS, CULTURED; CHROMANS; HYPERTHYROIDISM; MALE; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; THYROID HORMONES; VITAMIN E;

EID: 78651436732     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.12.018     Document Type: Article

References (36)

1. Araujo A.S., Ribeiro M.F., Enzveiler A., Schenkel P., Fernandes T.R., Partata W.A., Irigoyen M.C., Llesuy S., Bello-Klein A. Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism. Mol. Cell. Endocrinol. 2006, 249:133-139.
2. Araujo A.S., Enzveiler A.T., Schenkel P., Fernandes T.R., Ribeiro M.F., Partata W.A., Llesuy S., Bello-Klein A. Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine. Mol. Cell. Biochem. 2007, 303:89-95.
3. Araujo A.S., Schenkel P., Enzveiler A.T., Fernandes T.R., Partata W.A., Llesuy S., Ribeiro M.F., Khaper N., Singal P.K., Bello-Klein A. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J. Mol. Endocrinol. 2008, 41:423-430.
4. Barreto-Chaves M.L., Heimann A., Krieger J.E. Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz. J. Med. Biol. Res. 2000, 33:661-664.
5. Bello-Klein A., Oliveira A.R., Miranda M.F., Irigoyen M.C., Homem-de-Bittencourt P.I., Llesuy S., Bello A.A. Effect of Trolox C on cardiac contracture induced by hydrogen peroxide. Braz. J. Med. Biol. Res. 1997, 30:1337-1342.
6. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. 1984, 105:429-435.
7. Carneiro-Ramos M.S., da Silva V.B., Coutinho M.B., Battastini A.M., Sarkis J.J., Barreto-Chaves M.L. Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes. Mol. Cell. Biochem. 2004, 265:195-201.
8. Carneiro-Ramos M.S., Diniz G.P., Nadu A.P., Almeida J., Vieira R.L., Santos R.A., Barreto-Chaves M.L. Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res. Cardiol. 2010, 105:325-335.
9. Cericatto R., Pozzobon A., Morsch D.M., Menke C.H., Brum I.S., Spritzer P.M. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features. Steroids 2005, 70:153-160.
10. Chen K., Carey L.C., Valego N.K., Rose J.C. Thyroid hormone replacement normalizes renal renin and angiotensin receptor expression in thyroidectomized fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R701-706.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
12. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res. Cardiol. 2009, 104:653-667.
13. Garciarena C.D., Caldiz C.I., Correa M.V., Schinella G.R., Mosca S.M., Chiappe de Cingolani G.E., Cingolani H.E., Ennis I.L. Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J. Appl. Physiol. 2008, 105:1706-1713.
14. Granger D.L., Anstey N.M., Miller W.C., Weinberg J.B. Measuring nitric oxide production in human clinical studies. Methods Enzymol. 1999, 301:49-61.
15. Hu L.W., Benvenuti L.A., Liberti E.A., Carneiro-Ramos M.S., Barreto-Chaves M.L. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R1473-1480.
16. Kahaly G.J., Dillmann W.H. Thyroid hormone action in the heart. Endocr. Rev. 2005, 26:704-728.
17. Kenessey A., Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J. Biol. Chem. 2006, 281:20666-20672.
18. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 2001, 344:501-509.
19. Klein I., Danzi S. Thyroid disease and the heart. Circulation 2007, 116:1725-1735.
20. Kobori H., Ichihara A., Suzuki H., Takenaka T., Miyashita Y., Hayashi M., Saruta T. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am. J. Physiol. 1997, 273:H593-599.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Laragh J.H., Sealey J.E. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT. Am. J. Hypertens. 2003, 16:407-415.
23. Lindpaintner K., Lu W., Neidermajer N., Schieffer B., Just H., Ganten D., Drexler H. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J. Mol. Cell. Cardiol. 1993, 25:133-143.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
25. Matsusaka H., Kinugawa S., Ide T., Matsushima S., Shiomi T., Kubota T., Sunagawa K., Tsutsui H. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction. J. Cardiovasc. Pharmacol. 2006, 48:95-102.
26. Mujoo K., Sharin V.G., Bryan N.S., Krumenacker J.S., Sloan C., Parveen S., Nikonoff L.E., Kots A.Y., Murad F. Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18924-18929.
27. Nakagami H., Takemoto M., Liao J.K. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2003, 35:851-859.
28. Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J. Immunol. Methods 1980, 38:161-170.
29. Ritchie R.H., Schiebinger R.J., LaPointe M.C., Marsh J.D. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. Am. J. Physiol. 1998, 275:H1370-1374.
30. Rodriguez-Gomez I., Wangensteen R., Moreno J.M., Chamorro V., Osuna A., Vargas F. Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1252-1257.
31. Saraiva R.M., Hare J.M. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr. Opin. Cardiol. 2006, 21:221-228.
32. Senbonmatsu T., Ichihara S., Price E., Gaffney F.A., Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest. 2000, 106:R25-29.
33. Soccio M., Toniato E., Evangelista V., Carluccio M., De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur. J. Clin. Invest. 2005, 35:305-314.
34. Sun Y. Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. J. Mol. Cell. Cardiol. 2010, 48:483-489.
35. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
36. Vargas F., Moreno J.M., Wangensteen R., Rodriguez-Gomez I., Garcia-Estan J. The endocrine system in chronic nitric oxide deficiency. Eur. J. Endocrinol. 2007, 156:1-12.